Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi-Lepri

Showing results (1-10 of 244) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|February 13, 2022
Another piece in the COVID-19 treatment puzzleCristina Mussini, Alessandro Cozzi-Lepri
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 12, 2021
Signals were broadly positive for months, but never definitive: the tocilizumab storyAlessandro Cozzi-Lepri, Colette Smith, Cristina Mussini
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 8, 2021
Re: 'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et alAlessandro Cozzi-Lepri, Giovanni Guaraldi, Marianna Meschiari, et al.
Current HIV Research|October 30, 2015
Computer-Aided Optimization of Combined Anti-Retroviral Therapy for HIV: New Drugs, New Drug Targets and Drug ResistanceMaurizio Zazzi, Alessandro Cozzi-Lepri, Mattia C F Prosperi
Lancet (London, England)|May 22, 2002
Early assessment of anti-HIV drug efficacyLucy Paddam, Caroline Sabin, Alessandro Cozzi Lepri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2024
COVID-19: Find the Right Questions to be AnsweredAndrea Giacomelli, Spinello Antinori, Andrea Gori, et al.
European Journal of Public Health|January 14, 2026
Mortality risk for healthcare workers and journalists in the Gaza Strip over 2023-24Francesca Incardona, Federica Bellerba, Sara Gandini, et al.
The Journal of Antimicrobial Chemotherapy|May 25, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA Study-authors' responseAntonella d'Arminio Monforte, Alessandro Tavelli, Andrea Antinori, et al.
The Journal of Infectious Diseases|November 9, 2014
Reply to ManfrediMiriam Lichtner, Serena Vita, Alessandro Cozzi Lepri, et al.
AIDS (London, England)|September 10, 2003
Definition of loss of virological response in trials of antiretroviral drugsSchlomo Staszewski, Caroline Sabin, Brenda Dauer, et al.
Pageof 25

Showing results (1-10 of 244) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|February 13, 2022
Another piece in the COVID-19 treatment puzzleCristina Mussini, Alessandro Cozzi-Lepri
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 12, 2021
Signals were broadly positive for months, but never definitive: the tocilizumab storyAlessandro Cozzi-Lepri, Colette Smith, Cristina Mussini
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 8, 2021
Re: 'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et alAlessandro Cozzi-Lepri, Giovanni Guaraldi, Marianna Meschiari, et al.
Current HIV Research|October 30, 2015
Computer-Aided Optimization of Combined Anti-Retroviral Therapy for HIV: New Drugs, New Drug Targets and Drug ResistanceMaurizio Zazzi, Alessandro Cozzi-Lepri, Mattia C F Prosperi
Lancet (London, England)|May 22, 2002
Early assessment of anti-HIV drug efficacyLucy Paddam, Caroline Sabin, Alessandro Cozzi Lepri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2024
COVID-19: Find the Right Questions to be AnsweredAndrea Giacomelli, Spinello Antinori, Andrea Gori, et al.
European Journal of Public Health|January 14, 2026
Mortality risk for healthcare workers and journalists in the Gaza Strip over 2023-24Francesca Incardona, Federica Bellerba, Sara Gandini, et al.
The Journal of Antimicrobial Chemotherapy|May 25, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA Study-authors' responseAntonella d'Arminio Monforte, Alessandro Tavelli, Andrea Antinori, et al.
The Journal of Infectious Diseases|November 9, 2014
Reply to ManfrediMiriam Lichtner, Serena Vita, Alessandro Cozzi Lepri, et al.
AIDS (London, England)|September 10, 2003
Definition of loss of virological response in trials of antiretroviral drugsSchlomo Staszewski, Caroline Sabin, Brenda Dauer, et al.
Pageof 25